Cargando…

Interventions and Impact of Pharmacist-Delivered Services for People Infected with COVID-19: A Systematic Review

Pharmacists are essential members of the healthcare team. The emergence of the novel coronavirus disease 2019 (COVID-19) pandemic has led pharmacists to undertake additional clinical roles. We aim to conduct a systematic review on the interventions and impact of pharmacist-delivered services in mana...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Ali, Tanveer, Maria, Shrestha, Sunil, Khatiwada, Asmita Priyadarshini, Khanal, Saval, Dujaili, Juman Abdulelah, Paudyal, Vibhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498522/
https://www.ncbi.nlm.nih.gov/pubmed/36141242
http://dx.doi.org/10.3390/healthcare10091630
_version_ 1784794780057731072
author Ahmed, Ali
Tanveer, Maria
Shrestha, Sunil
Khatiwada, Asmita Priyadarshini
Khanal, Saval
Dujaili, Juman Abdulelah
Paudyal, Vibhu
author_facet Ahmed, Ali
Tanveer, Maria
Shrestha, Sunil
Khatiwada, Asmita Priyadarshini
Khanal, Saval
Dujaili, Juman Abdulelah
Paudyal, Vibhu
author_sort Ahmed, Ali
collection PubMed
description Pharmacists are essential members of the healthcare team. The emergence of the novel coronavirus disease 2019 (COVID-19) pandemic has led pharmacists to undertake additional clinical roles. We aim to conduct a systematic review on the interventions and impact of pharmacist-delivered services in managing COVID-19 patients. We searched PubMed, Embase, Scopus, CINAHL plus, International Pharmaceutical Abstracts, and Web of Science from 1 December 2019 (the first case of COVID-19 emerged) to 13 January 2022 to retrieve the articles. Cochrane handbook and PRISMA guidelines were followed respectively to perform and report the review. The pharmacist-led interventions were reported following the Descriptive Elements of Pharmacist Intervention Characterization Tool (DEPICT) version 2. The protocol of systematic review was registered on PROSPERO (CRD42021277128). Studies quality was assessed with the modified NOS scale. In total, 7 observational studies were identified from 10,838 studies. Identification of dosage errors (n = 6 studies), regimen modifications (n = 5), removal of obsolete/duplicate medications (n = 5), identification and management of adverse drug reactions (n = 4), drug interactions prevention (n = 2), and physicians acceptance rate (n = 3) of therapy-related services delivered in-person or via tele-pharmacy were among the pharmacist-delivered services. Common interventions delivered by pharmacists also included optimizing the use of antibacterial, antivirals, and anticoagulants in COVID-19 infected patients. The acceptance of pharmacist-delivered services by physicians was high (88.5–95.5%). Included studies have described pharmacists’ beneficial role in managing patients with COVID-19 including detection, resolution, and prevention of medication-related problems, with physicians demonstrating high trust in pharmacists’ advice. Future research should assess the feasibility and scalability of such roles in real-world settings.
format Online
Article
Text
id pubmed-9498522
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94985222022-09-23 Interventions and Impact of Pharmacist-Delivered Services for People Infected with COVID-19: A Systematic Review Ahmed, Ali Tanveer, Maria Shrestha, Sunil Khatiwada, Asmita Priyadarshini Khanal, Saval Dujaili, Juman Abdulelah Paudyal, Vibhu Healthcare (Basel) Review Pharmacists are essential members of the healthcare team. The emergence of the novel coronavirus disease 2019 (COVID-19) pandemic has led pharmacists to undertake additional clinical roles. We aim to conduct a systematic review on the interventions and impact of pharmacist-delivered services in managing COVID-19 patients. We searched PubMed, Embase, Scopus, CINAHL plus, International Pharmaceutical Abstracts, and Web of Science from 1 December 2019 (the first case of COVID-19 emerged) to 13 January 2022 to retrieve the articles. Cochrane handbook and PRISMA guidelines were followed respectively to perform and report the review. The pharmacist-led interventions were reported following the Descriptive Elements of Pharmacist Intervention Characterization Tool (DEPICT) version 2. The protocol of systematic review was registered on PROSPERO (CRD42021277128). Studies quality was assessed with the modified NOS scale. In total, 7 observational studies were identified from 10,838 studies. Identification of dosage errors (n = 6 studies), regimen modifications (n = 5), removal of obsolete/duplicate medications (n = 5), identification and management of adverse drug reactions (n = 4), drug interactions prevention (n = 2), and physicians acceptance rate (n = 3) of therapy-related services delivered in-person or via tele-pharmacy were among the pharmacist-delivered services. Common interventions delivered by pharmacists also included optimizing the use of antibacterial, antivirals, and anticoagulants in COVID-19 infected patients. The acceptance of pharmacist-delivered services by physicians was high (88.5–95.5%). Included studies have described pharmacists’ beneficial role in managing patients with COVID-19 including detection, resolution, and prevention of medication-related problems, with physicians demonstrating high trust in pharmacists’ advice. Future research should assess the feasibility and scalability of such roles in real-world settings. MDPI 2022-08-26 /pmc/articles/PMC9498522/ /pubmed/36141242 http://dx.doi.org/10.3390/healthcare10091630 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ahmed, Ali
Tanveer, Maria
Shrestha, Sunil
Khatiwada, Asmita Priyadarshini
Khanal, Saval
Dujaili, Juman Abdulelah
Paudyal, Vibhu
Interventions and Impact of Pharmacist-Delivered Services for People Infected with COVID-19: A Systematic Review
title Interventions and Impact of Pharmacist-Delivered Services for People Infected with COVID-19: A Systematic Review
title_full Interventions and Impact of Pharmacist-Delivered Services for People Infected with COVID-19: A Systematic Review
title_fullStr Interventions and Impact of Pharmacist-Delivered Services for People Infected with COVID-19: A Systematic Review
title_full_unstemmed Interventions and Impact of Pharmacist-Delivered Services for People Infected with COVID-19: A Systematic Review
title_short Interventions and Impact of Pharmacist-Delivered Services for People Infected with COVID-19: A Systematic Review
title_sort interventions and impact of pharmacist-delivered services for people infected with covid-19: a systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498522/
https://www.ncbi.nlm.nih.gov/pubmed/36141242
http://dx.doi.org/10.3390/healthcare10091630
work_keys_str_mv AT ahmedali interventionsandimpactofpharmacistdeliveredservicesforpeopleinfectedwithcovid19asystematicreview
AT tanveermaria interventionsandimpactofpharmacistdeliveredservicesforpeopleinfectedwithcovid19asystematicreview
AT shresthasunil interventionsandimpactofpharmacistdeliveredservicesforpeopleinfectedwithcovid19asystematicreview
AT khatiwadaasmitapriyadarshini interventionsandimpactofpharmacistdeliveredservicesforpeopleinfectedwithcovid19asystematicreview
AT khanalsaval interventionsandimpactofpharmacistdeliveredservicesforpeopleinfectedwithcovid19asystematicreview
AT dujailijumanabdulelah interventionsandimpactofpharmacistdeliveredservicesforpeopleinfectedwithcovid19asystematicreview
AT paudyalvibhu interventionsandimpactofpharmacistdeliveredservicesforpeopleinfectedwithcovid19asystematicreview